PDT Partners’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-39,933
| Closed | -$263K | – | 687 |
|
|
2023
Q2 | $263K | Hold |
39,933
| – | – | 0.04% | 474 |
|
|
2023
Q1 | $271K | Buy |
+39,933
| New | +$271K | 0.04% | 474 |
|
|
2022
Q4 | – | Sell |
-20,065
| Closed | -$198K | – | 907 |
|
|
2022
Q3 | $198K | Sell |
20,065
-20,742
| -51% | -$205K | 0.03% | 723 |
|
|
2022
Q2 | $445K | Buy |
40,807
+18,027
| +79% | +$197K | 0.04% | 631 |
|
|
2022
Q1 | $258K | Buy |
22,780
+10,322
| +83% | +$117K | 0.02% | 764 |
|
|
2021
Q4 | $195K | Buy |
+12,458
| New | +$195K | 0.01% | 768 |
|
|
2021
Q3 | – | Sell |
-57,998
| Closed | -$1.25M | – | 925 |
|
|
2021
Q2 | $1.25M | Buy |
57,998
+1,004
| +2% | +$21.6K | 0.08% | 334 |
|
|
2021
Q1 | $856K | Buy |
56,994
+11,033
| +24% | +$166K | 0.06% | 397 |
|
|
2020
Q4 | $604K | Sell |
45,961
-35,639
| -44% | -$468K | 0.04% | 419 |
|
|
2020
Q3 | $788K | Sell |
81,600
-15,948
| -16% | -$154K | 0.05% | 348 |
|
|
2020
Q2 | $1.12M | Buy |
97,548
+67,412
| +224% | +$771K | 0.08% | 266 |
|
|
2020
Q1 | $312K | Buy |
+30,136
| New | +$312K | 0.02% | 474 |
|
|
2017
Q3 | – | Sell |
-98,360
| Closed | -$1.6M | – | 571 |
|
|
2017
Q2 | $1.6M | Sell |
98,360
-10,500
| -10% | -$171K | 0.06% | 280 |
|
|
2017
Q1 | $1.52M | Hold |
108,860
| – | – | 0.08% | 258 |
|
|
2016
Q4 | $1.74M | Sell |
108,860
-10,800
| -9% | -$172K | 0.11% | 263 |
|
|
2016
Q3 | $1.99M | Buy |
119,660
+3,900
| +3% | +$64.9K | 0.12% | 226 |
|
|
2016
Q2 | $1.3M | Sell |
115,760
-12,400
| -10% | -$139K | 0.1% | 235 |
|
|
2016
Q1 | $1.07M | Sell |
128,160
-46,400
| -27% | -$388K | 0.07% | 303 |
|
|
2015
Q4 | $1.63M | Sell |
174,560
-105,155
| -38% | -$979K | 0.22% | 165 |
|
|
2015
Q3 | $3.16M | Buy |
279,715
+170,625
| +156% | +$1.92M | 0.07% | 319 |
|
|
2015
Q2 | $1.38M | Buy |
+109,090
| New | +$1.38M | 0.04% | 621 |
|